Phase I study of Iressa [gefitinib] and CRT [chemo radio-therapy]/IMRT [intensity modulated radiation therapy] in Chinese patients with IIIB/IV NSCLC [non-small cell lung cancer] after failure of platinum-based chemotherapy

Trial Profile

Phase I study of Iressa [gefitinib] and CRT [chemo radio-therapy]/IMRT [intensity modulated radiation therapy] in Chinese patients with IIIB/IV NSCLC [non-small cell lung cancer] after failure of platinum-based chemotherapy

Recruiting
Phase of Trial: Phase I

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Gefitinib (Primary)
  • Indications Non-small cell lung cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 09 Aug 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top